Morphic forms of danicopan

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 11814363
APP PUB NO 20230094124A1
SERIAL NO

17272924

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

This invention provides stable, highly crystalline forms of Complement factor D inhibitors Compound 1 for advantageous therapeutic pharmaceutical efficacy and dosage form stability.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ACHILLION PHARMACEUTICALS INC300 GEORGE STREET NEW HAVEN CT 06511

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Hashimoto, Akihiro Branford, US 142 2601
Katrincic, Lee M Durham, US 10 71
Ma, Wei Cary, US 151 949
Phadke, Avinash Branford, US 63 516

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 May 14, 2027
7.5 Year Payment $3600.00 $1800.00 $900.00 May 14, 2031
11.5 Year Payment $7400.00 $3700.00 $1850.00 May 14, 2035
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00